Fujian Aonong Biological Technology Group Incorporation Limited Class A

Fujian Aonong Biological Technology Group Incorporation Limited Class A

SSSE:603363
2.63
CNY
-0.09
(-3.31%)
-0.37EPS
7.67BMarket Cap
Apr 26Next Earn
Fujian Aonong Biological Technology Group Incorporation Limited Class A
SSE:603363
(Shanghai Stock Exchange)

Recent

price

2.63

P/E

ratio

- -

div

yld

1.08%

ROIC.AI

2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
CNY
22.72
7.66
9.14
10.48
10.12
10.3
9.93
19.1
27.77
27.89
22.44
10.13
3.28
3.91
Revenue per Share
0.19
0.08
0.08
0.19
0.22
0.05
0.05
0.95
-2.34
-1.34
-4.21
0.67
0.03
-0.31
Basic EPS, GAAP
- -
-0.35
-0.18
-0.31
-0.82
-0.97
-0.45
-4.79
-3.36
-1.08
0.54
-0.44
-0.03
- -
Free Cash Flow per Basic Share
0.03
0.02
0.1
0.04
0.05
0.13
0.14
0.31
0.53
0.42
0.34
0.09
0.03
0.03
Dividend per Share
0.72
1.31
0.98
1.01
1.48
1.47
1.47
4.07
1.9
2.88
-1.11
0.98
1.2
1.01
Book Value per Share
0.55
0.94
0.78
0.78
1.19
1.11
0.86
2.84
0.51
1.62
-2.04
0.73
0.95
0.78
Tangible Book Value per Share
130
546
439
475
485
559
583
603
650
775
867
865
2,587
2,343
Basic Weighted Avg Shares
2,954
4,184
4,013
4,978
4,903
5,762
5,788
11,517
18,038
21,613
19,458
8,763
8,475
9,162
Sales/Revenue/Turnover
1.57
1.23
1.96
2.96
4.15
2.15
3.79
10.92
-4.43
-1.19
-10.88
-8.52
-0.47
-5.46
Operating Margin (%)
- -
17
34
52
73
105
155
327
1,042
1,290
1,235
833
473
- -
Depreciation Expense
25
43
34
91
108
30
29
573
-1,520
-1,038
-3,651
579
78
-728
Net Income, GAAP
33.83
12.63
29.46
10.09
17.94
48.48
- -
- -
- -
- -
- -
25.33
15.12
- -
Effective Tax Rate (%)
0.85
1.02
0.84
1.84
2.21
0.52
0.5
4.98
-8.43
-4.8
-18.76
6.61
0.92
-7.95
Profit Margin (%)
-102
-143
-120
-149
-51
-756
-1,868
-2,812
-5,854
-6,530
-8,570
-915
-234
-604
Working Capital
- -
11
23
90
256
212
14
2,931
4,474
3,110
2,345
1,638
1,452
1,386
LT Debt
106
215
445
594
966
1,008
1,284
3,903
2,193
3,435
-503
3,061
3,580
3,083
Total Equity
- -
9.47
6.42
12.09
9.16
0.57
- -
- -
- -
- -
- -
4.7
1.43
- -
Return on Invested Capital (%)
- -
19.08
7.1
10.52
8.67
4.32
- -
- -
- -
- -
- -
23.4
3.15
- -
Return on Capital (%)
- -
32.35
12.24
21.39
16.87
3.72
3.55
32.1
-75.14
-54.52
- -
- -
2.73
-24.51
Return on Common Equity (%)

Capital Structure

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
918
972
969
LT Borrowings
1,259
1,213
1,196
LT Finance Leases
163
195
190
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
2,603
2,731
2,731
Market Capitalization
10,073
7,319
7,674

Working Capital

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
3,511
3,485
3,625
Cash, Cash Equivalents & STI
441
486
492
Accounts Receivable, Net
719
721
771
Inventories
1,162
1,067
1,199
Total Current Liabilities
3,778
3,915
4,229
Payables & Accruals
- -
- -
- -
ST Debt
918
972
969
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-46.15%
-158.64%
16.96%
Free Cash Flow
73.63%
-100.54%
-79.72%
Net Income, GAAP
163.09%
-69.56%
-86.6%
Sales/Revenue/Turnover
14.77%
1.64%
-3.29%
Total Cash Common Dividend
31.3%
1.41%
10.62%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
2,408
2,248
2,269
1,838
8,763
2025
1,783
2,174
- -
2,140
8,475
2026
2,206
2,315
2,502
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.34
-0.28
-0.32
1.16
0.67
2025
0.08
0.05
- -
-0.13
0.03
2026
-0.01
-0.06
-0.07
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.03
0.02
0.01
0.01
0.09
2025
- -
0.01
- -
0.02
0.03
2026
- -
- -
- -
- -
- -
Business
Fujian Aonong Biological Technology Group Incorporation Limited (603363.SS) is a China-based agricultural and animal husbandry company principally engaged in feed production, pig breeding, slaughtering and food processing, veterinary pharmaceuticals, supply chain services, and raw materials trading. The company manufactures and sells a diverse range of animal feeds including pig feed, poultry feed, aquatic feed, ruminant feed, and related premixes; operates pig breeding farms producing piglets, fattening pigs, and breeding sows; conducts pig slaughtering, meat processing, and sales of pork and meat products; and provides veterinary products such as pharmaceutical preparations, additives, powders, injections, oral liquids, solid and liquid disinfectants. It also develops digital platforms encompassing pig management systems (pig OK), meat traceability, IoT breeding equipment, e-commerce for pig customers, feed ERP, and dealer management tools, primarily serving domestic farmers, agricultural enterprises, and livestock sectors across China with headquarters in Zhangzhou, Fujian province, where it was founded in 2011. Recent developments include a 73% surge in pig sales volume to 190,200 heads in October 2025, alongside a 19.39% year-on-year increase in live pig breeding stock to 605,100 heads by end-August 2025, reflecting robust operational expansion in its core pig farming segment; additionally, affiliates linked to director Chen Mingyi completed an equity transfer and ownership transition in *ST Tianshan, a livestock breeding firm, for 287 million yuan in August 2025, signaling strategic moves into related cattle and dairy operations.